References
- Aghaei M, Motallebnezhad M, Ghorghanlu S, et al. Targeting autophagy in cardiac ischemia/reperfusion injury: a novel therapeutic strategy. J Cell Physiol. 2019;234(10):16768–16778. doi:https://doi.org/10.1002/jcp.28345. PMID:30807647.
- Theodoraki K, Karmaniolou I, Tympa A, et al. Beyond preconditioning: postconditioning as an alternative technique in the prevention of liver ischemia-reperfusion injury. Oxid Med Cell Longev. 2016;2016:8235921. doi:https://doi.org/10.1155/2016/8235921. PMID:27340509.
- Olthof PB, van Golen RF, Meijer B, et al. Warm ischemia time-dependent variation in liver damage, inflammation, and function in hepatic ischemia/reperfusion injury. Biochim Biophys Acta Mol Basis Dis. 2017;1863(2):375–385. doi:https://doi.org/10.1016/j.bbadis.2016.10.022. PMID:27989959.
- Lu L, Zhou H, Ni M, et al. Innate immune regulations and liver ischemia-reperfusion injury. Transplantation. 2016;100(12):2601–2610. doi:https://doi.org/10.1097/TP.0000000000001411. PMID:27861288.
- Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology. 2000;32(2):169–173. doi:https://doi.org/10.1053/jhep.2000.9323. PMID:10915720.
- Cuzzocrea S. Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury. Vascul Pharmacol. 2004;41(6):187–195. doi:https://doi.org/10.1016/j.vph.2004.10.004. PMID:15653094.
- Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med. 2002;53:409–435. doi:https://doi.org/10.1146/annurev.med.53.082901.104018. PMID:11818483.
- Xi Y, Zhang Y, Zhu S, Luo Y, Xu P, Huang Z. PPAR-mediated toxicology and applied pharmacology. Cells. 2020;9(2):352. PMID:32028670. doi:https://doi.org/10.3390/cells9020352.
- Spiegelman BM. Peroxisome proliferator-activated receptor gamma: a key regulator of adipogenesis and systemic insulin sensitivity. Eur J Med Res. 1997;2(11):457–464. PMID:9385114.
- Sekulic-Jablanovic M, Petkovic V, Wright MB, et al. Effects of peroxisome proliferator activated receptors (PPAR)-gamma and -alpha agonists on cochlear protection from oxidative stress. PLoS One. 2017;12(11):e0188596. doi:https://doi.org/10.1371/journal.pone.0188596. PMID:29182629.
- Ma Y, Wang B, Li L, Wang F, Xia X. The administration of peroxisome proliferator-activated receptors alpha/gamma agonist TZD18 inhibits cell growth and induces apoptosis in human gastric cancer cell lines. J Cancer Res Ther. 2019;15(1):120–125. doi:https://doi.org/10.4103/0973-1482.208753. PMID:30880766.
- Kapadia R, Yi JH, Vemuganti R. Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci. 2008;13:1813–1826. doi:https://doi.org/10.2741/2802. PMID:17981670.
- Rapuano R, Ziccardi P, Cioffi V, Dallavalle S, Moricca S, Lupo A. Cladosporols A and B, two natural peroxisome proliferator-activated receptor gamma (PPARgamma) agonists, inhibit adipogenesis in 3T3-L1 preadipocytes and cause a conditioned-culture-medium-dependent arrest of HT-29 cell proliferation. Biochim Biophys Acta Gen Subj. 2021;1865(11):129973. doi:https://doi.org/10.1016/j.bbagen.2021.129973. PMID:34352342.
- Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem. 2008;77:289–312. doi:https://doi.org/10.1146/annurev.biochem.77.061307.091829. PMID:18518822.
- Abdelrahman M, Sivarajah A, Thiemermann C. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock. Cardiovasc Res. 2005;65(4):772–781. doi:https://doi.org/10.1016/j.cardiores.2004.12.008. PMID:15721857.
- Akahori T, Sho M, Hamada K, et al. Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice. J Hepatol. 2007;47(6):784–792. doi:https://doi.org/10.1016/j.jhep.2007.07.030. PMID:17936399.
- Kuboki S, Shin T, Huber N, et al. Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. Hepatology. 2008;47(1):215–224. doi:https://doi.org/10.1002/hep.21963. PMID:18085707.
- Chandra M, Miriyala S, Panchatcharam M. PPARgamma and its role in cardiovascular diseases. PPAR Res. 2017;2017:6404638. doi:https://doi.org/10.1155/2017/6404638. PMID:28243251.
- Nakajima A, Wada K, Miki H, et al. Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology. 2001;120(2):460–469. doi:https://doi.org/10.1053/gast.2001.21191. PMID:11159886.
- Liu C, Chen X, Yang L, Kisseleva T, Brenner DA, Seki E. Transcriptional repression of the transforming growth factor beta (TGF-beta) pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by nuclear factor kappaB (NF-kappaB) p50 enhances TGF-beta signalling in hepatic stellate cells. J Biol Chem. 2014;289(10):7082–7091. doi:https://doi.org/10.1074/jbc.M113.543769. PMID:24448807.
- Yoshidome H, Kato A, Edwards MJ, Lentsch AB. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. Hepatology. 1999;30(1):203–208. doi:https://doi.org/10.1002/hep.510300120. PMID:10385657.
- Li JD, Peng Y, Peng XY, Li QL, Li Q. Suppression of nuclear factor-kappaB activity in Kupffer cells protects rat liver graft from ischemia-reperfusion injury. Transplant Proc. 2010;42(5):1582–1586. PMID:20620478. doi:https://doi.org/10.1016/j.transproceed.2009.12.077.
- Samokhvalov V, Vriend J, Jamieson KL, et al. PPARgamma signalling is required for mediating EETs protective effects in neonatal cardiomyocytes exposed to LPS. Front Pharmacol. 2014;5:242. doi:https://doi.org/10.3389/fphar.2014.00242. PMID:25426073.
- Liu Y, Lu T, Zhang C, et al. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury. J Hepatol. 2019;71(4):719–730. doi:https://doi.org/10.1016/j.jhep.2019.05.029. PMID:31201834.
- Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation. 1993;55(6):1265–1272. doi:https://doi.org/10.1097/00007890-199306000-00011. PMID:7685932.
- Kamo N, Shen XD, Ke B, Busuttil RW, Kupiec-Weglinski JW. Sotrastaurin, a protein kinase C inhibitor, ameliorates ischemia and reperfusion injury in rat orthotopic liver transplantation. Am J Transplant. 2011;11(11):2499–2507. doi:https://doi.org/10.1111/j.1600-6143.2011.03700.x. PMID:21883905.
- Liu X, Yu Z, Huang X, et al. Peroxisome proliferator-activated receptor gamma (PPARgamma) mediates the protective effect of quercetin against myocardial ischemia-reperfusion injury via suppressing the NF-kappaB pathway. Am J Transl Res. 2016;8(12):5169–5186. PMID:28077993
- Ye L, He S, Mao X, Zhang Y, Cai Y, Li S. Effect of hepatic macrophage polarisation and apoptosis on liver ischemia and reperfusion injury during liver transplantation. Front Immunol. 2020;11:1193. doi:https://doi.org/10.3389/fimmu.2020.01193. PMID:32676077.
- Chiş IC, Baltaru D, Dumitrovici A, et al. Protective effects of quercetin from oxidative/nitrosative stress under intermittent hypobaric hypoxia exposure in the rat’s heart. Physiol Int. 2018;105(3):233–246. doi:https://doi.org/10.1556/2060.105.2018.3.23. PMID:30282485.
- Yang X, Li C, Ng KT, et al. IL-17a exacerbates hepatic ischemia-reperfusion injury in fatty liver by promoting neutrophil infiltration and mitochondria-driven apoptosis. J Leukoc Biol. 2020;108(5):1603–1613. doi:https://doi.org/10.1002/JLB.3MA0520-716R. PMID:32531822.
- Bosman MCJ, Schepers H, Jaques J, et al. The TAK1-NF-kappaB axis as therapeutic target for AML. Blood. 2014;124(20):3130–3140. doi:https://doi.org/10.1182/blood-2014-04-569780. PMID:25287709.
- Wang G, Han T, Wang S, Chen M, Sun Y, Fu Z. Peroxisome proliferator-activated receptor-gamma prevents cholesterol gallstone formation in C57bl mice by regulating bile acid synthesis and enterohepatic circulation. Biomed Res Int. 2018;2018:7475626. doi:https://doi.org/10.1155/2018/7475626. PMID:30105244.
- Han T, Lv Y, Wang S, Hu T, Hong H, Fu Z. Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet. Lipids Health Dis. 2019;18(1):218. doi:https://doi.org/10.1186/s12944-019-1159-4. PMID:31829191.
- Lee SM, Pusec CM, Norris GH, et al. Hepatocyte-specific loss of PPARgamma protects mice from NASH and increases the therapeutic effects of rosiglitazone in the liver. Cell Mol Gastroenterol Hepatol. 2021;11(5):1291–1311. doi:https://doi.org/10.1016/j.jcmgh.2021.01.003. PMID:33444819.
- Han T, Lv Y, Wang S, Hu T, Hong H, Fu Z. PPARgamma overexpression regulates cholesterol metabolism in human L02 hepatocytes. J Pharmacol Sci. 2019;139(1):1–8. doi:https://doi.org/10.1016/j.jphs.2018.09.013. PMID:30554802.
- Huang R, Zhang C, Wang X, Hu H. PPARgamma in Ischemia-reperfusion injury: overview of the biology and therapy. Front Pharmacol. 2021;12:600618. doi:https://doi.org/10.3389/fphar.2021.600618. PMID:33995008.
- Linares I, Farrokhi K, Echeverri J, et al. PPAR-gamma activation is associated with reduced liver ischemia-reperfusion injury and altered tissue-resident macrophages polarisation in a mouse model. PLoS One. 2018;13(4):e0195212. doi:https://doi.org/10.1371/journal.pone.0195212. PMID:29617419.
- Yang W, Chen J, Meng Y, Chen Z, Yang J. Novel targets for treating ischemia-reperfusion injury in the liver. IJMS. 2018;19(5):1302. PMID:29701719. doi:https://doi.org/10.3390/ijms19051302.
- Li Y, Guan Y, Wang Y, Yu CL, Zhai FG, Guan LX. Neuroprotective effect of the ginsenoside Rg1 on cerebral ischemic injury in vivo and in vitro is mediated by PPARgamma-regulated antioxidative and anti-Inflammatory pathways. Evid Based Complement Alternat Med. 2017;2017:7842082. doi:https://doi.org/10.1155/2017/7842082. PMID:28656054.
- Chaudhry A, Carthan KA, Kang BY, Calvert J, Sutliff RL, Michael Hart C. PPARgamma attenuates hypoxia-induced hypertrophic transcriptional pathways in the heart. Pulm Circ. 2017;7(1):98–107. doi:https://doi.org/10.1086/689749. PMID:28680569.
- Jimenez-Castro MB, Cornide-Petronio ME, Gracia-Sancho J, Peralta C. Inflammasome-mediated inflammation in liver ischemia-reperfusion injury. Cells. 2019;8(10):1131. PMID:31547621. doi:https://doi.org/10.3390/cells810.
- Duda DG, Dima SO, Cucu D, et al. Potential circulating biomarkers of recurrence after hepatic resection or liver transplantation in hepatocellular carcinoma patients. Cancers (Basel). 2020;12(5):1275. PMID:32443546. doi:https://doi.org/10.3390/cancers12051275.
- Du ZA, Sun MN, Hu ZS. Saikosaponin a ameliorates LPS-induced acute lung injury in mice. Inflammation. 2018;41(1):193–198. doi:https://doi.org/10.1007/s10753-017-0677-3. PMID:28986747.
- Elias-Miro M, Jimenez-Castro MB, Rodes J, Peralta C. Current knowledge on oxidative stress in hepatic ischemia/reperfusion. Free Radic Res. 2013;47(8):555–568. doi:https://doi.org/10.3109/10715762.2013.811721. PMID:23738581.
- Bautista-Perez R, Cano-Martinez A, Gutierrez-Velazquez E, et al. Spinach methanolic extract attenuates the retinal degeneration in diabetic rats. Antioxidants (Basel). 2021;10(5):717. PMID:34063668. doi:https://doi.org/10.3390/antiox10050717.
- Feng SQ, Zong SY, Liu JX, et al. VEGF antagonism attenuates cerebral ischemia/reperfusion-induced injury via inhibiting endoplasmic reticulum stress-mediated apoptosis. Biol Pharm Bull. 2019;42(5):692–702. doi:https://doi.org/10.1248/bpb.b18-00628. PMID:30828041.
- Fischer S, Nasyrov E, Brosien M, Preissner KT, Marti HH, Kunze R. Self-extracellular RNA promotes pro-inflammatory response of astrocytes to exogenous and endogenous danger signals. J Neuroinflammation. 2021;18(1):252. doi:https://doi.org/10.1186/s12974-021-02286-w. PMID:34727934.
- Fawzy MA, Maher SA, Bakkar SM, El-Rehany MA, Fathy M. Pantoprazole attenuates MAPK (ERK1/2, JNK, p38)-NF-kappaB and apoptosis signalling pathways after renal ischemia/reperfusion injury in rats. IJMS. 2021;22(19):10669. PMID:34639009. doi:https://doi.org/10.3390/ijms221910669.
- Zhang S, Feng Z, Gao W, et al. Aucubin attenuates liver ischemia-reperfusion injury by inhibiting the HMGB1/TLR-4/NF-kappaB signalling pathway, oxidative stress, and apoptosis. Front Pharmacol. 2020;11:544124. doi:https://doi.org/10.3389/fphar.2020.544124. PMID:33013386.
- Kunicka Z, Kurzynska A, Szydlowska A, Mierzejewski K, Bogacka I. Peroxisome proliferator-activated receptor gamma ligands affect NF-kB and cytokine synthesis in the porcine endometrium-an in vitro study. Am J Reprod Immunol. 2019;81(1):e13053. doi:https://doi.org/10.1111/aji.13053. PMID:30265413.
- Liu YI, Liu Z, Chen Y, Xu K, Dong J. PPARgamma activation reduces ischemia/reperfusion-induced metastasis in a murine model of hepatocellular carcinoma. Exp Ther Med. 2016;11(2):387–396. doi:https://doi.org/10.3892/etm.2015.2934. PMID:26893620.